| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/07/2006 | EP1663156A2 Chronotherapeutic dosage forms |
| 06/07/2006 | EP1663155A2 Dry powder composition comprising co-jet milled particles for pulmonary inhalation |
| 06/07/2006 | EP1663153A1 Combination chemotherapy comprising a liposomal platinum complex |
| 06/07/2006 | EP1663151A2 Mucoactive agents for treating a pulmonary disease |
| 06/07/2006 | EP1663150A2 Novel inhalation powder comprising the cgrp antagonist 1-[ n2-[3,5-dibromo-n-[[4-(3,4-dihydro-2(1h)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-d-tyrosyl]-l-lysyl]-4-(4-pyridinyl)-piperazine |
| 06/07/2006 | EP1663149A2 Spray-dried amorphous bibn 4096 method for production and use thereof as inhalant |
| 06/07/2006 | EP1663148A2 Penetrating pharmaceutical foam |
| 06/07/2006 | EP1663145A1 Oros-push-stick for controlled delivery of active agents |
| 06/07/2006 | EP1663144A1 Triamcinolone acetonide and anecortave acetate formulations for injection |
| 06/07/2006 | EP1663141A1 Aqueous pharmaceutical solution containing oxymetazoline and/or xylometazoline |
| 06/07/2006 | EP1663131A1 Parasiticidal composition |
| 06/07/2006 | EP1663124A1 Antimicrobial compositions and methods of use |
| 06/07/2006 | EP1663114A2 Therapeutic immunization of hiv-infected individuals |
| 06/07/2006 | EP1663113A2 Substituted sulfonamides |
| 06/07/2006 | EP1663112A2 Intranasal opioid compositions |
| 06/07/2006 | EP1663107A2 Rifamycin analogs and uses thereof |
| 06/07/2006 | EP1663106A2 Pharmaceutical composition, method of manufacturing and therapeutic use thereof |
| 06/07/2006 | EP1663105A2 Cycloalkyl heterocycles for treating hepatitis c virus |
| 06/07/2006 | EP1663104A2 Porifera-based therapeutic compositions for treating and preventing skin diseases |
| 06/07/2006 | EP1663103A2 Compositions of botanical extracts for cancer therapy |
| 06/07/2006 | EP1663061A2 Use of melatonin-containing oral supplement with animals |
| 06/07/2006 | EP1662976A2 THERMALLY MODIFIED MICROBIAL-DERIVED CELLULOSE FOR i IN VIVO /i IMPLANTATION |
| 06/07/2006 | EP1662965A2 Formulations and methods for treating breast cancer with morinda citrifolia and methylsulfonymethane |
| 06/07/2006 | EP1662912A2 An edible mix and method of making the same |
| 06/07/2006 | EP1662908A1 Composition and method for facilitating bone healing |
| 06/07/2006 | EP1662906A1 Compositions for the treatment and prevention of diabetes mellitus |
| 06/07/2006 | EP1662876A2 Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |
| 06/07/2006 | EP1662875A2 Chelerythrine, analogs thereof and their use in the treatment of bipolar disorder and other cognitive disorders |
| 06/07/2006 | EP1662874A2 Co-administration of polysaccharide with a chemotherapeutic agent for the treatment of cancer |
| 06/07/2006 | EP1599469B1 Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof |
| 06/07/2006 | EP1567516B1 Method for the purification of liponic acid |
| 06/07/2006 | EP1560578B1 Use of the distrontium salt of the acid 2-¬n,n-di(carboxymethyl)amino|-3-cyano-4-carboxymethyl-thiophen-5-carboxylate for the production of medicaments for the treatment of gastro-duodenal pain |
| 06/07/2006 | EP1540338A4 Bioequivalence test for iron-containing formulations |
| 06/07/2006 | EP1494999B1 Occlusive composition comprising a poly(2-cyanoacrylate) monomer |
| 06/07/2006 | EP1492789B1 Tropane derivatives as ccr5 modulators |
| 06/07/2006 | EP1453447A4 Composition and transdermal drug delivery device |
| 06/07/2006 | EP1446106A4 Optimal polymer mixtures for gastric retentive tablets |
| 06/07/2006 | EP1427723B1 Tetrahydropyran derivatives and their use as therapeutic agents |
| 06/07/2006 | EP1425029A4 Peptidomimetics of biologically active metallopeptides |
| 06/07/2006 | EP1423145B1 Compositions for the treatment of parkinson's disease containing a cb1 receptor antagonist and a product that activates dopaminergic neurotransmission in the brain |
| 06/07/2006 | EP1421075B1 Piperidine derivatives useful as ccr5 antagonists for the treatment of hiv |
| 06/07/2006 | EP1411899A4 Taste masking composition |
| 06/07/2006 | EP1406878B1 4-(benzylidene-amino)-3-(methylsulfanyl)-4h-(1, 2, 4) triazin-5-one derivatives having a pde-iv inhibiting and tnf-antagonistic effect for the treatment of cardiac diseases and allergies |
| 06/07/2006 | EP1406614B1 Carvedilol polymorph |
| 06/07/2006 | EP1383523B1 Agent for treating diabetes mellitus |
| 06/07/2006 | EP1378510B1 Triazaspiro (5.5) undecane derivatives and drugs containing the same as the active ingredient |
| 06/07/2006 | EP1373188B1 Alanine 2,6-dialkoxyphenyl ester derivatives as hypnotics |
| 06/07/2006 | EP1369416B1 Stable crystals of pyrrole compound |
| 06/07/2006 | EP1368355B1 Substituted pyrazolopyrimidines and thiazolopyrimidines |
| 06/07/2006 | EP1355889B1 Substituted triazole diamine derivatives as kinase inhibitors |
| 06/07/2006 | EP1334367B1 A method of determining the initial dose of vitamin d compounds |
| 06/07/2006 | EP1315732B1 Radicicol and monocillin and their analogues and uses thereof |
| 06/07/2006 | EP1311478B1 Novel (thio)urea compounds and the pharmaceutical compositions containing the same |
| 06/07/2006 | EP1309559B1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 06/07/2006 | EP1305009B1 Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
| 06/07/2006 | EP1296673A4 Antimicrobial coatings |
| 06/07/2006 | EP1285654B1 Autonomic system controlling agents and health drinks and foods |
| 06/07/2006 | EP1259489B1 Aryl fused azapolycyclic compounds |
| 06/07/2006 | EP1222931B1 Percutaneous absorption promoters for electroporation |
| 06/07/2006 | EP1200063B1 Treatment and composition for achieving skin anti-aging benefits by corneum protease activation |
| 06/07/2006 | EP1174126B1 Antibody and polyalkylene glycol-bonded liposome |
| 06/07/2006 | EP1162969B1 use of dipeptidyl peptidase IV inhibitors fOR IMPROVING FERTILITY |
| 06/07/2006 | EP1148783B1 Converting cox inhibition compounds that are not cox-2 selective inhibitors to derivatives that are cox-2 selective inhibitors |
| 06/07/2006 | EP1147113B1 Fused heterocyclic compounds and their use in the treatment of neurodegenerative diseases |
| 06/07/2006 | EP1140965B1 Antibacterial protonated oligonucleotides |
| 06/07/2006 | EP1121941B1 Sorbefacients and preparations for percutaneous absorption containing the same |
| 06/07/2006 | EP1104307B1 Pharmaceutical composition having inhibitory effect on overproduction and accumulation of extracellular matrix |
| 06/07/2006 | EP1102583B1 Treatment of addiction to nicotine and addiction-related behavior |
| 06/07/2006 | EP1071463B1 Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors |
| 06/07/2006 | EP1068870B1 Antitumor agents |
| 06/07/2006 | EP1056725B1 Inhibition of raf kinase using aryl and heteroaryl substituted heterocyclic ureas |
| 06/07/2006 | EP1002081B1 Delayed progression to aids by a missense allele of the ccr2 gene |
| 06/07/2006 | EP0934065B1 Novel cryptophycin derivatives as anti-neoplastic agents |
| 06/07/2006 | EP0929298B1 Pharmaceutical compositions comprising s-(-)-n-propargyl-1-amino indan |
| 06/07/2006 | EP0871735B1 Therapeutic compositions for the treatment of Lawsonia intracellularis infections |
| 06/07/2006 | EP0822809B1 Controlled release formulation for water soluble drugs in which a passageway is formed in situ |
| 06/07/2006 | EP0813538B1 Compositions and methods for the treatment and diagnosis of immune disorders |
| 06/07/2006 | EP0772437B1 Compositions for delivery of genetic material |
| 06/07/2006 | CN1784901A System and method for processing a digital television signal having multiple content ratings each one associated with different content rating system |
| 06/07/2006 | CN1784426A Antibody targeted at antigen specific to cancer |
| 06/07/2006 | CN1784415A Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 06/07/2006 | CN1784410A Protein kinase inhibitors |
| 06/07/2006 | CN1784408A 8-substituted-6,7,8,9-tetrahy9dropyrimido (1,2-a) pyrimidin-4-one derivatives |
| 06/07/2006 | CN1784406A Purification and crystalline forms of zaleplon |
| 06/07/2006 | CN1784405A Microcrystal |
| 06/07/2006 | CN1784404A Isoquinoline-3-carboxylic acid amides and pharmaceutical uses thereof |
| 06/07/2006 | CN1784403A Azaindole compounds as kinase inhibitors |
| 06/07/2006 | CN1784402A Imidazo and thiazolopyridines as JAK3 kinase inhibitors |
| 06/07/2006 | CN1784401A Novel fused triazolones and the uses thereof |
| 06/07/2006 | CN1784400A Quinuclidine derivatives binding to mucarinic M3 receptors |
| 06/07/2006 | CN1784398A 4-(2-furoyl)aminopiperidine compound useful as therapeutic agent for itching |
| 06/07/2006 | CN1784397A Methyl indoles and methyl pyrrolopyridines as alph-1 adrenergic agonists |
| 06/07/2006 | CN1784396A P38 inhibitors and methods of use thereof |
| 06/07/2006 | CN1784395A Piperazine-alkyl-ureido derivatives |
| 06/07/2006 | CN1784394A Novel piperidine derivatives |
| 06/07/2006 | CN1784393A Chemical compounds |
| 06/07/2006 | CN1784392A Benzothiazole derivative compounds,compositions and uses |
| 06/07/2006 | CN1784391A Quinazolines useful as modulators of ion channels |
| 06/07/2006 | CN1784390A Substituted dihydrochinazolines having antiviral properties |
| 06/07/2006 | CN1784387A Benzimidazole derivatives |